Validation of a radiobiological model for low-dose-rate prostate boost focal therapy treatment planning.

Abstract:

PURPOSE:Low-dose-rate brachytherapy using iodine-125 seeds is a highly efficacious treatment for low-risk prostate cancer. We propose a bioeffect model may be used to target an ablative dose to the tumor with a lower, therapeutic dose to low-risk regions to maintain high rates of tumor control with reduced toxicity. We report on the validation of the model and derivation of the optimal cutpoint value of tumor control probability (TCP) that predicts for freedom from biochemical failure. METHODS AND MATERIALS:The TCP was calculated from postimplant dosimetry data for 423 prostate cancer patients from three Australian institutions. To apply the model, the prostate was mathematically divided into 12 subsections with tumor characteristics, including a nonuniform distribution of tumor cell density, derived from the literature. RESULTS:When TCP values were above and below 0.62, the 5-year freedom from biochemical failure were 93.7% (95% confidence interval [CI], 90.4, 96.4%) and 88.8% (95% confidence interval, 81.3, 94.5%), respectively (p = 0.004). CONCLUSIONS:Using postimplant dosimetry data, the TCP model was able to predict for freedom from biochemical failure. The cutpoint value that would be used clinically depends on the selection of the model parameters, but the potential for the model to be used in the optimization of treatment planning is demonstrated.

journal_name

Brachytherapy

journal_title

Brachytherapy

authors

Haworth A,Williams S,Reynolds H,Waterhouse D,Duchesne GM,Bucci J,Joseph D,Bydder S,Ebert M

doi

10.1016/j.brachy.2013.04.008

subject

Has Abstract

pub_date

2013-11-01 00:00:00

pages

628-36

issue

6

eissn

1538-4721

issn

1873-1449

pii

S1538-4721(13)00275-4

journal_volume

12

pub_type

杂志文章,多中心研究
  • Radioactive gold grain implants in recurrent and locally advanced head-and-neck cancers.

    abstract:PURPOSE:The radioactive gold grain applicator and seeds offer the flexibility necessary for effective use in the treatment of difficult sites of head-and-neck cancers. This study reviews our experience with gold grain (198Au) implants in locally advanced head-and-neck cancer to demonstrate their efficacy and feasibilit...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/s1538-4721(02)00054-5

    authors: Ashamalla H,Rafla S,Zaki B,Ikoro NC,Ross P

    更新日期:2002-01-01 00:00:00

  • Bone HDR brachytherapy in a patient with recurrent Ewing's sarcoma of the acetabulum: alternative to aggressive surgery.

    abstract::A 17-year-old girl diagnosed with a previously irradiated, locally recurrent Ewing's sarcoma involving the puboischiatic rami and the adjacent acetabulum was referred to our institution for consideration of salvage hindquarter resection. A conservative resection with implantation of the acetabular remnant for high-dos...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/S1538-4721(03)00098-9

    authors: Martínez-Monge R,Pérez-Ochoa A,San Julián M,Aquerreta D,Sierrasesúmaga L

    更新日期:2003-01-01 00:00:00

  • Radiation oncology and medical physicists quality assurance in British Columbia Cancer Agency Provincial Prostate Brachytherapy Program.

    abstract:PURPOSE:To describe in detail British Columbia (BC) Cancer Agency (BCCA) Provincial Prostate Brachytherapy (PB) Quality Assurance (QA) Program. METHODS AND MATERIALS:The BCCA PB Program was established in 1997. It operates as one system, unified and supported by electronic and information systems, making it a single P...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2012.03.006

    authors: Keyes M,Morris WJ,Spadinger I,Araujo C,Cheung A,Chng N,Crook J,Halperin R,Lapointe V,Miller S,Pai H,Pickles T

    更新日期:2013-07-01 00:00:00

  • Monte Carlo calculation of the dose perturbations in a dual-source HDR/PDR afterloader treatment unit.

    abstract:PURPOSE:Currently, there are high dose rate afterloaders available that can drive two different radioactive sources simultaneously. The source-source and source-cable attenuations are not taken into account by current planning systems. The purpose of this work is to characterize these effects and their overall impact o...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2016.03.007

    authors: Collins-Fekete CA,Plamondon M,Verhaegen F,Beaulieu L

    更新日期:2016-07-01 00:00:00

  • Selection of patients who would not require long-term prostate-specific antigen monitoring after low-dose-rate brachytherapy.

    abstract:PURPOSE:To identify patients at extremely low risk of biochemical recurrence (BCR) of prostate cancer after low-dose-rate brachytherapy (LDR-BT) to determine when prostate-specific antigen (PSA) monitoring can be stopped. METHODS AND MATERIALS:We retrospectively reviewed clinicopathologic data of patients with prostat...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2018.08.018

    authors: Niwa N,Matsumoto K,Nishiyama T,Yagi Y,Ozu C,Nakamura K,Saito S,Oya M

    更新日期:2018-01-01 00:00:00

  • Prospective evaluation of patient satisfaction after the use of brachytherapy specific educational materials for cervical cancer.

    abstract:BACKGROUND:Cervical cancer patients are faced with an enormous amount of medical information in a complex oncology field with sophisticated treatments including brachytherapy. We investigated the use of enhanced vs. standard brachytherapy-specific educational materials on patient-reported satisfaction during the inform...

    journal_title:Brachytherapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.brachy.2015.09.007

    authors: Rash D,Hess C,Lentz S,Tait L,Michaud A,Mayadev J

    更新日期:2016-01-01 00:00:00

  • Frequency of whole breast radiation therapy after intraoperative radiation therapy due to criteria identified by lumpectomy.

    abstract:PURPOSE:For selected early breast cancers, intraoperative radiation therapy (IORT) at the time of lumpectomy can be an efficient alternative to fractionated whole breast radiation therapy (WBRT). However, some patients are later recommended WBRT after IORT due to surgical pathologic findings. To understand risk factor ...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2016.09.012

    authors: Mellon EA,Orman A,Joya LE,Montejo ME,Laronga C,Hoover SJ,Lee MC,Khakpour N,Kubal PF,Diaz R

    更新日期:2017-01-01 00:00:00

  • Interstitial brachytherapy in the management of persistent head and neck disease after definitive external beam radiation therapy.

    abstract:PURPOSE:Persistent disease after definitive external beam radiation therapy for head and neck (H&N) malignancies negatively impacts survival. In this series, the effectiveness of low-dose-rate brachytherapy in the management of persistent H&N disease is explored. METHODS:All patients who received brachytherapy for per...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2008.12.007

    authors: Grimard L,Esche B,Lamothe A,Spaans JN

    更新日期:2009-07-01 00:00:00

  • Evaluating the influence of prostate-specific antigen kinetics on metastasis in men with PSA recurrence after partial gland therapy.

    abstract:PURPOSE:Although current Delphi Consensus guidelines do not recommend a specific definition of biochemical recurrence after partial gland therapy, these guidelines acknowledge that serial prostate-specific antigen (PSA) tests remain the best marker for monitoring disease after treatment. The purpose of this study was t...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2018.12.001

    authors: King MT,Nguyen PL,Boldbaatar N,Yang DD,Muralidhar V,Tempany CM,Cormack RA,Hurwitz MD,Suh WW,Pomerantz MM,D'Amico AV,Orio PF 3rd

    更新日期:2019-01-01 00:00:00

  • The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer.

    abstract:PURPOSE:With accumulating evidence supporting partial-breast irradiation, we conducted a Phase I/II study to evaluate the role of a second conservative surgery and brachytherapy for patients presenting with a local recurrence/new primary in a breast who has previously undergone a lumpectomy and external radiation thera...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2007.10.006

    authors: Chadha M,Feldman S,Boolbol S,Wang L,Harrison LB

    更新日期:2008-01-01 00:00:00

  • Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer.

    abstract:PURPOSE:HDRILBT is one of the best methods of palliation for advanced esophageal cancer (AEC) by improving dysphagia-free survival (DFS) and overall survival (OS). This study examines if the addition of EBRT would further improve the outcome by improving DFS in AEC. METHODS AND MATERIALS:Patients with inoperable AEC w...

    journal_title:Brachytherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/j.brachy.2004.09.004

    authors: Sur R,Donde B,Falkson C,Ahmed SN,Levin V,Nag S,Wong R,Jones G

    更新日期:2004-01-01 00:00:00

  • Online correction of catheter movement using CT in high-dose-rate prostate brachytherapy.

    abstract:PURPOSE:To present a clinical procedure that readjusts catheters to its planned positions based on pretreatment computed tomography (CT) for patients undergoing high-dose-rate (HDR) prostate brachytherapy, and evaluate the magnitude and dosimetric impact of the adjustments. METHODS AND MATERIALS:Patients received a pr...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2012.08.008

    authors: Huang Y,Miller B,Doemer A,Babij D,Kumar S,Frontera R,Nurushev T,Chetty IJ,Aref I

    更新日期:2013-05-01 00:00:00

  • Morbidity and prostate-specific antigen control of external beam radiation therapy plus low-dose-rate brachytherapy boost for low, intermediate, and high-risk prostate cancer.

    abstract:PURPOSE:Dose escalation has been shown beneficial in prostate cancer. Brachytherapy (BT) provides an opportunity for dose escalation beyond what can be safely delivered using only teletherapy methods. The purpose of this study was to determine cancer control and morbidity of external beam radiation therapy (EBRT) plus ...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2009.01.002

    authors: Koontz BF,Chino J,Lee WR,Hahn CA,Buckley N,Huang S,Kim J,Reagan R,Joyner R,Anscher MS

    更新日期:2009-04-01 00:00:00

  • Evaluation of a collapsed-cone convolution algorithm for esophagus and surface mold 192Ir brachytherapy treatment planning.

    abstract:PURPOSE:TG43 does not account for a lack of scatter and tissue and applicator heterogeneities. The advanced collapsed-cone engine (ACE) algorithm available for use in the Oncentra Brachy treatment planning system (Elekta AB, Stockholm, Sweden) can model these conditions more accurately and is evaluated for esophageal a...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2020.09.006

    authors: Eason L,Mason J,Cooper R,Radhakrishna G,Bownes P

    更新日期:2020-10-15 00:00:00

  • Quantitative estimation of doses to salivary glands from using brachytherapy in head and neck cancers.

    abstract:PURPOSE:To quantify the percentage doses received by salivary glands (SGDs) in head and neck interstitial brachytherapy (BT). METHODS AND MATERIALS:The study included 43 patients who underwent high-dose rate iridium-192 implant for oral cavity and oropharyngeal lesions treated with BT as a boost. BT dose varied with d...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2010.03.001

    authors: Bhalavat RL,Vyas S,Jamema SV,Upreti R,Talole S,Medhi S

    更新日期:2011-01-01 00:00:00

  • Evaluation of impact of an external breast shield (FlexiShield) in electronic brachytherapy for breast IORT: A phantom study.

    abstract:PURPOSE:To investigate Axxent (iCAD, Inc., San Jose, CA) electronic brachytherapy balloon deformation and its dosimetric impact because of an external flexible shield (FlexiShield [FS]; iCAD, Inc.). METHODS AND MATERIALS:Prostheses breast tissue phantom overlaid three spherical balloon applicators to simulate three cl...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2017.01.009

    authors: Kim Y,Huynh JW,Gonzalez VJ

    更新日期:2017-01-01 00:00:00

  • Preclinical study investigating the potential of low-dose-rate brachytherapy with 32P stents for the prevention of restenosis of paranasal neo-ostia.

    abstract:PURPOSE:Ostial restenosis is a common cause of failures in paranasal sinus surgery. The aim of the current study was to investigate the use of low-dose-rate brachytherapy to prevent neo-ostial restenosis in an animal model. METHODS AND MATERIALS:In 14 rabbits, maxillary neo-ostia were created and measured. One side ea...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2016.08.011

    authors: Oestreicher E,Bartsch H,Mayr D,Schubert M,Weber B,Kneschaurek P,Assmann W,Sroka R,Betz CS

    更新日期:2017-01-01 00:00:00

  • High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience.

    abstract:PURPOSE:Treatment options are limited for patients with localized prostate cancer and a prior history of abdominoperineal resection (APR) and pelvic irradiation. We have previously reported on the successful utility of high-dose-rate (HDR) brachytherapy salvage for prostate cancer failing definitive external beam radia...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2009.02.004

    authors: Jabbari S,Hsu IC,Kawakami J,Weinberg VK,Speight JL,Gottschalk AR,Roach M 3rd,Shinohara K

    更新日期:2009-10-01 00:00:00

  • Optimization of prostate brachytherapy techniques with polyethylene glycol-based hydrogel spacers: A systematic review.

    abstract:PURPOSE:The objective of this overview was to critically evaluate the effect of polyethylene glycol (PEG)-based hydrogel spacers during prostate brachytherapy with regard to dosimetric and clinical benefits, as well as procedure-related toxicity. METHODS AND MATERIALS:A systematic search in the PubMed database was per...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2019.08.009

    authors: Afkhami Ardekani M,Ghaffari H

    更新日期:2020-01-01 00:00:00

  • Clinical outcomes using image-guided interstitial brachytherapy for definitive cervical cancer patients with high-risk clinical target volumes greater than 30 cc.

    abstract:PURPOSE:Given the limited data using an interstitial approach with 3D-based planning for definitive cervical cancer utilizing the GEC-ESTRO defined high-risk clinical target volume (HR-CTV), we reviewed our institutional experience of cervical cancer patients with HR-CTVs ≥ 30 cc to determine whether our clinical and t...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2017.10.004

    authors: Wang C,Raince J,Swamy U,Park SJ,Zaide L,Mesko S,Demanes DJ,Kamrava M

    更新日期:2018-01-01 00:00:00

  • Clinical outcomes with MRI-guided image-based brachytherapy in cervical cancer: An institutional experience.

    abstract:PURPOSE:To evaluate the long-term disease control and toxicity to the organs at risk after dose-escalated image-based adaptive brachytherapy (BT) in cervical cancer. METHODS AND MATERIALS:Sixty patients of cervical cancer were treated with external radiotherapy 46 Gy in 23 fractions with weekly cisplatin and MRI-guide...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2017.09.008

    authors: Simha V,Rai B,Patel FD,Kapoor R,Sharma SC,Singh OA,Singla V,Dhanireddy B,Ghoshal S

    更新日期:2018-01-01 00:00:00

  • Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.

    abstract:PURPOSE:To evaluate lumpectomy followed by interstitial brachytherapy as an acceptable salvage therapy for women who have developed localized recurrence of breast cancer after conservation surgery and postoperative external radiotherapy. METHODS AND MATERIALS:Between 1/1998 and 10/2006, 21 patients with T0 or T1 in-br...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2007.12.001

    authors: Trombetta M,Julian T,Bhandari T,Werts ED,Miften M,Parda D

    更新日期:2008-01-01 00:00:00

  • Long-term efficacy and urological toxicity of low-dose-rate brachytherapy (LDR-BT) as monotherapy in localized prostate cancer.

    abstract:PURPOSE:The purpose of this study was to evaluate the incidence of late severe (≥Grade 3) urinary toxicity and the long-term efficacy after low-dose-rate brachytherapy (LDR-BT) in patients with localized prostate cancer (PCa). METHODS AND MATERIALS:During the years 1999-2008, 241 patients with PCa who underwent LDR-BT...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2019.05.005

    authors: Vuolukka K,Auvinen P,Palmgren JE,Voutilainen T,Aaltomaa S,Kataja V

    更新日期:2019-01-01 00:00:00

  • Substantial lymphovascular space invasion predicts worse outcomes in early-stage endometrioid endometrial cancer.

    abstract:INTRODUCTION:Substantial as opposed to focal or no lymphovascular space invasion (LVSI) is proposed as an independent adverse prognostic factor in patients with early-stage endometrioid endometrial cancer (EEC). We reviewed outcomes of patients treated with adjuvant vaginal brachytherapy (VB) alone in a single institut...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2020.12.006

    authors: Barnes EA,Martell K,Parra-Herran C,Taggar AS,Donovan E,Leung E

    更新日期:2021-01-20 00:00:00

  • Novel and programmatic improvements to the workflow associated with the AccuBoost breast brachytherapy procedure.

    abstract:PURPOSE:While the noninvasive breast brachytherapy (NIBB) treatment procedure, known as AccuBoost, for breast cancer patients is well established, the treatment quality can be improved by the efficiency of the workflow delivery. A formalized approach evaluated the current workflow through failure modes and effects anal...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2020.01.007

    authors: Roles SA,Hepel JT,Leonard KL,Wazer DE,Cardarelli GA,Schwer ML,Saleh ZH,Klein EE,Brindle JM,Rivard MJ

    更新日期:2020-01-01 00:00:00

  • Variations in health-related quality of life in Japanese men who underwent iodine-125 permanent brachytherapy for localized prostate cancer.

    abstract:PURPOSE:The purpose of this study was to prospectively assess the variations in health-related quality of life (HR-QoL) in patients who underwent low-dose rate prostate brachytherapy using iodine-125 seed source during the first year after seed implantation. METHODS AND MATERIALS:Between July 2004 and December 2006, 1...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2009.07.013

    authors: Tanaka N,Fujimoto K,Asakawa I,Hirayama A,Yoneda T,Yoshida K,Hirao Y,Hasegawa M,Konishi N

    更新日期:2010-10-01 00:00:00

  • Concurrent chemoradiation for cervical cancer: Comparison of LDR and HDR brachytherapy.

    abstract:PURPOSE:To compare clinical outcomes between low-dose-rate (LDR) brachytherapy and high-dose-rate (HDR) brachytherapy for cervical cancer patients. METHODS AND MATERIALS:All consecutive newly diagnosed cervical cancer patients undergoing pretreatment 18-fluorodeoxyglucose positron emission tomography imaging and treat...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2018.11.008

    authors: Lin AJ,Samson P,Zoberi J,Garcia-Ramirez J,Williamson JF,Markovina S,Schwarz J,Grigsby PW

    更新日期:2019-01-01 00:00:00

  • Single-energy metal artifact reduction in postimplant computed tomography for I-125 prostate brachytherapy: Impact on seed identification.

    abstract:PURPOSE:To evaluate the effectiveness of the single-energy metal artifact reduction (SEMAR) technique for improving the accuracy of I-125 seed identification in postimplant computed tomography (CT) after prostate brachytherapy. METHODS AND MATERIALS:Postimplant CT images of 40 patients treated with I-125 prostate brac...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2016.07.006

    authors: Shiraishi Y,Yamada Y,Tanaka T,Eriguchi T,Nishimura S,Yoshida K,Hanada T,Ohashi T,Shigematsu N,Jinzaki M

    更新日期:2016-01-01 00:00:00

  • A new short daily brachytherapy schedule in postoperative endometrial carcinoma. Preliminary results.

    abstract:PURPOSE:To evaluate the preliminary results of vaginal-cuff relapses (VCR) and complications of a short brachytherapy (BT) schedule in postoperative endometrial carcinoma. METHODS AND MATERIALS:From September 2011 to December 2014, 102 patients were treated with postoperative BT for endometrial carcinoma. Seventy-four...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2016.10.001

    authors: Rovirosa Á,Ascaso C,Herreros A,Sánchez J,Holub K,Camarasa A,Sabater S,Oses G,García-Miguel J,Rivera Y,Arenas M

    更新日期:2017-01-01 00:00:00

  • The effect of isotope selection on the prostate-specific antigen response in patients treated with permanent prostate brachytherapy.

    abstract:PURPOSE:To assess the difference in prostate-specific antigen (PSA) response kinetics in patients undergoing either (125)I or (103)Pd permanent prostate brachytherapy (PPB). METHODS AND MATERIALS:Between 1997 and 1999, 333 patients underwent PPB as monotherapy. Forty-eight patients received a (125)I implant, and 285 r...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/S1538-4721(03)00004-7

    authors: Potters L,Huang D,Fearn P,Kattan MW

    更新日期:2003-01-01 00:00:00